FERRARESI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 3.042
EU - Europa 700
AS - Asia 599
OC - Oceania 4
SA - Sud America 1
Totale 4.346
Nazione #
US - Stati Uniti d'America 3.027
CN - Cina 289
UA - Ucraina 199
SG - Singapore 179
IT - Italia 133
DE - Germania 122
TR - Turchia 112
GB - Regno Unito 88
FI - Finlandia 50
SE - Svezia 33
BE - Belgio 22
CA - Canada 15
FR - Francia 11
PL - Polonia 10
CZ - Repubblica Ceca 7
ID - Indonesia 6
LT - Lituania 6
RO - Romania 6
IN - India 5
IE - Irlanda 4
IR - Iran 3
RU - Federazione Russa 3
AU - Australia 2
DK - Danimarca 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
VN - Vietnam 2
AL - Albania 1
JP - Giappone 1
NL - Olanda 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.346
Città #
Woodbridge 353
Fairfield 313
Chandler 249
Ann Arbor 224
Jacksonville 223
Houston 216
Santa Clara 197
Ashburn 148
Singapore 146
Seattle 143
Wilmington 124
Cambridge 108
Izmir 72
Boardman 71
Ferrara 68
Nanjing 67
New York 64
Beijing 51
Princeton 48
Shanghai 29
Dearborn 23
Shenyang 23
Brussels 22
Milan 22
San Diego 22
Jiaxing 19
Los Angeles 16
Nanchang 16
Bremen 15
Jinan 14
Hebei 13
Tianjin 13
Auburn Hills 11
Falls Church 11
Düsseldorf 10
Warsaw 10
London 9
Ottawa 9
Redwood City 9
Bologna 7
Helsinki 7
Mountain View 7
San Mateo 7
Washington 7
Brno 6
Jakarta 6
Norwalk 6
Changsha 5
Florence 5
Monmouth Junction 5
Munich 5
Ningbo 5
Chicago 4
Frankfurt am Main 4
Philadelphia 4
Taizhou 4
Toronto 4
Zhengzhou 4
Ardabil 3
Augusta 3
Falkenstein 3
Kunming 3
Leawood 3
Orange 3
Auckland 2
Cherasco 2
Copenhagen 2
Des Moines 2
Dong Ket 2
Dublin 2
Haikou 2
Hefei 2
Hong Kong 2
Lappeenranta 2
Padova 2
Paris 2
Swansea 2
Acton 1
Bellinzago Lombardo 1
Bratislava 1
Bray 1
Celbridge 1
Changchun 1
Chengdu 1
Clifton 1
Dongguan 1
Ferrara di Monte Baldo 1
Forest City 1
Hangzhou 1
Hanover 1
Hounslow 1
Hyderabad 1
Jinhua 1
Lima 1
Marienheide 1
Mercer Island 1
Motta Di Livenza 1
New Delhi 1
Newmarket 1
North Bergen 1
Totale 3.370
Nome #
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 152
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 145
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 134
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 128
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 121
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 121
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 119
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 118
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. 116
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 114
Factor IX propeptide mutation and life threatening bleeding 113
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 113
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 110
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 110
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 107
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 104
null 103
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency 102
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 98
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 98
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 97
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 86
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 86
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 85
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 84
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 83
null 82
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 80
null 78
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 78
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 76
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 75
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 73
null 73
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 72
Factor VIIa levels, gene polymorphism and plasma lipids in subjects with or without angiographically proven coronary artery disease 71
Modulation Of Factor VII Expression By Repeat And Sequence Variations In The Intron 7 Of FVII Gene: Population And In Vitro Studies 71
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 65
Non-conventional therapeutic strategies for inherited disorders of hemostasis 64
Strong contribution of FVII genotypes to activated FVII levels and differences in genotype frequencies in northern and southern European countries 63
null 61
null 61
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 60
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 57
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 53
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 39
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 38
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 36
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 32
Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype 27
The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. 24
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 19
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 17
Totale 4.392
Categoria #
all - tutte 19.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020507 0 0 0 0 0 107 87 94 71 101 36 11
2020/2021580 59 44 25 66 34 61 28 72 14 71 82 24
2021/2022476 21 55 34 23 21 9 24 15 9 32 62 171
2022/2023525 56 53 16 79 75 79 18 41 63 2 23 20
2023/2024354 31 26 7 6 30 78 10 26 9 19 11 101
2024/2025473 29 20 115 36 147 126 0 0 0 0 0 0
Totale 4.392